Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer.
Ontology highlight
ABSTRACT: Pancreatic cancer has become the third leading cause of cancer-related death in the Western world despite advances in therapy of other cancerous lesions. Late diagnosis due to a lack of symptoms during early disease allows metastatic spread of the tumor. Most patients are considered incurable because of metastasized disease. On a cellular level, pancreatic cancer proves to be rather resistant to chemotherapy. Hence, early detection and new therapeutic targets might improve outcomes. The detection of DNA promoter hypermethylation has been described as a method to identify putative genes of interest in cancer entities. These genes might serve as either biomarkers or might lead to a better understanding of the molecular mechanisms involved. We checked tumor specimens from 80 patients who had
SUBMITTER: Wiesmueller F
PROVIDER: S-EPMC6862440 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA